Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.490
-0.060 (-2.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Akoya Biosciences Employees
Akoya Biosciences had 330 employees as of December 31, 2023. The number of employees decreased by 39 or -10.57% compared to the previous year.
Employees
330
Change (1Y)
-39
Growth (1Y)
-10.57%
Revenue / Employee
$263,076
Profits / Employee
-$175,661
Market Cap
123.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 330 | -39 | -10.57% |
| Dec 31, 2022 | 369 | 50 | 15.67% |
| Dec 31, 2021 | 319 | 150 | 88.76% |
| Dec 31, 2020 | 169 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| American Well | 1,104 |
| Protalix BioTherapeutics | 208 |
| Enanta Pharmaceuticals | 145 |
| Cabaletta Bio | 103 |
| Lineage Cell Therapeutics | 75 |
| InflaRx | 62 |
| Sensus Healthcare | 35 |
| Cassava Sciences | 29 |
AKYA News
- 11 days ago - Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions - GlobeNewsWire
- 5 weeks ago - Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Akoya Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 - GlobeNewsWire
- 2 months ago - Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy - GlobeNewsWire
- 2 months ago - Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors - GlobeNewsWire
- 4 months ago - Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Akoya Biosciences Reports Second Quarter 2024 Financial Results - GlobeNewsWire